Cynata Therapeutics Limited (ASX:CYP)

Cynata Therapeutics Revenue

Cynata Therapeutics had revenue of 1.77M AUD in the half year ending December 31, 2025, a decrease of -30.38%. This brings the company's revenue in the last twelve months to 1.69M, down -3.03% year-over-year. In the fiscal year ending June 30, 2025, Cynata Therapeutics had annual revenue of 1.89M, down -18.59%.

• Revenue (ttm): 1.69M
• Revenue Growth: -3.03%
• P/S Ratio: 1.88
• Revenue / Employee: 843.64K
• Employees: 2
• Market Cap: 3.16M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	1.89M	-430.50K	-18.59%
Jun 30, 2024	2.32M	661.33K	39.98%
Jun 30, 2023	1.65M	-6.12M	-78.71%
Jun 30, 2022	7.77M	6.22M	402.60%
Jun 30, 2021	1.55M	-5.47M	-77.95%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 12, 2026

Data Sources Report a data error